Skip to main content
≥99.0% HPLC Verified • SEPA Bank & Crypto • Min. Order €220
≥99.0% Lot SL-2026-123
FOXO4-DRI 10 mg — ≥99.0% analytical research vial
≥99.0%
Analytical Purity
24–48h Dispatch
CH/EU Cold-Chain
SL-2026-123
Active Batch Lot
Longevity & Cellular Biology • In stock — Ready to ship

FOXO4-DRI (10 mg)

€115 10 mg • EUR

FOXO4-DRI is a protease-resistant D-retro-inverso cell-penetrating peptide engineered to disrupt the nuclear FOXO4–p53 interaction, selectively triggering p53-mediated apoptosis in senescent cell models.

Chemical & Registry Specifications
CAS Registry Number 2460055-10-9
Molecular Formula C228H388N86O64
Molecular Weight 5358.13 g/mol
Counterion / Form Acetate lyophilized salt
Sequence / Structural Class D-Retro-Inverso 46-aa cell-penetrating peptide (FOXO4–p53 interface + HIV-TAT)
Primary Biological Target / Pathway FOXO4–p53 protein–protein interaction (senolytic pathway)
Cold-chain dispatch: CH 1–2d (Free) • EU 2–4d (€12, Free >€150) Shipping & returns
Min. order €220.00 • Payment via SEPA Bank Transfer (EUR) (request IBAN via LiveChat/email) or Crypto (BTC, ETH, USDT, USDC, SOL, XMR).

Scientific Profile & Research Key Points: FOXO4-DRI

FOXO4-DRI is a protease-resistant D-retro-inverso cell-penetrating peptide engineered to disrupt the nuclear FOXO4–p53 interaction, selectively triggering p53-mediated apoptosis in senescent cell models.

Full 46-residue D-retro-inverso synthesis (5358.13 Da)
Cell-penetrating HIV-TAT D-enantiomer domain intact
Verified protease-resistant chiral purity via RP-HPLC/MS
Primary Literature Reference Baar M.P. et al., Cell (2017) — Targeted apoptosis of senescent cells via FOXO4–p53 interference (PMID: 28340339)
View on PubMed ↗

Active Batch Release Specifications (Lot SL-2026-123)

Analytical release verification for current FOXO4-DRI (10 mg) inventory

Open Full Batch Registry
Batch Lot # Release Date Analytical Method Purity Spec Endotoxin (LAL) Moisture
SL-2026-123 2026-10-28 RP-HPLC (C18, 214nm) + ESI-MS ≥99.0% (Single Peak) <0.5 EU/mg <2.8% (Karl Fischer)

Laboratory Solubilization & Storage Protocol

Recommended Solvent / Handling

Sterile PBS (pH 7.4) or sterile 0.9% Bacteriostatic Water

Temperature & Stability

Store lyophilized at -20°C; protect from prolonged UV exposure due to D-Trp residue.

FOXO4-DRI — Technical Questions & Answers

What is the molar concentration when reconstituting FOXO4-DRI (10 mg) in 2.0 mL?

Reconstituting the full 10 mg vial of FOXO4-DRI (MW 5358.13 g/mol) in 2.0 mL of diluent produces a 5.00 mg/mL stock solution — equivalent to approximately 0.93 mM (933 µM) gross molarity before Net Peptide Content (NPC) adjustment.

How does FOXO4-DRI's counterion stoichiometry affect assay mass calculations?

FOXO4-DRI (CAS 2460055-10-9, formula C228H388N86O64) is supplied as Acetate lyophilized salt. Because counterions and residual bound water contribute to gross lyophilized weight, quantitative receptor-binding assays should apply batch Net Peptide Content (NPC) or active-ion correction rather than gross cake weight alone.

Which analytical methods verify FOXO4-DRI Lot SL-2026-123 and what pathway does it target?

Lot SL-2026-123 undergoes RP-HPLC (C18, 214nm) + ESI-MS confirming ≥99.0% (Single Peak) and identity against 5358.13 g/mol. In preclinical literature, FOXO4-DRI targets FOXO4–p53 protein–protein interaction (senolytic pathway) (Baar M.P. et al., Cell (2017) — Targeted apoptosis of senescent cells via FOXO4–p53 interference (PMID: 28340339)).

Research Use Only (RUO): FOXO4-DRI is supplied strictly for laboratory in-vitro experimentation and analytical investigation by qualified personnel. Not for human or veterinary administration.

Related Scientific Monographs

Peer-reviewed mechanism summaries and analytical protocols

All monographs (44)

Related Longevity & Cellular Biology Compounds

View category →
≥99.0%
Epitalon 10 mg — ≥99.0% Research Vial
Epitalon
10 mg In stock
CAS 307297-39-8
MW: 390.35 g/mol
€42
≥99.2%
GHK-Cu 50 mg — ≥99.2% Research Vial
GHK-Cu
50 mg In stock
CAS 49557-75-7
MW: 403.93 g/mol
€46
≥99.0%
Glow Blend 70 mg (50/10/10) — ≥99.0% Research Vial
Glow Blend
70 mg (50/10/10) In stock
CAS 49557-75-7 / 137525-51-0 / 77591-33-4
MW: 403.93 / 1419.53 / 4963.50 g/mol
€98
≥99.0%
Glutathione 1500 mg — ≥99.0% Research Vial
Glutathione
1500 mg In stock
CAS 70-18-8
MW: 307.32 g/mol
€45

Your Research Cart

0 items selected • Min. order €220

SEPA Bank Transfer & Crypto (BTC, ETH, USDT, USDC, SOL, XMR)
Min €220

Your cart is empty

Browse our catalog of research peptides and reagents (minimum order €220).

Browse Catalog